(Q40703649)

English

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

scientific article published on June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

van der Burg SH

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Kwappenberg KM

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

O'Neill T

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Brandt RM

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Melief CJ

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Hickling JK

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Offringa R

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3652-3660

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of invasive cervical cancer among women with, or at risk for, HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900086-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(01)00086-X

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40703649&oldid=1904954907"